Cencora Net Profit Margin 2012-2026 | COR
Current and historical net profit margin for Cencora (COR) from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue. Cencora net profit margin for the three months ending March 31, 2026 was .
| Cencora Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $328.68B | $2.55B | 0.78% |
| 2025-12-31 | $325.78B | $1.63B | 0.50% |
| 2025-09-30 | $321.33B | $1.55B | 0.48% |
| 2025-06-30 | $316.66B | $1.90B | 0.60% |
| 2025-03-31 | $310.23B | $1.69B | 0.55% |
| 2024-12-31 | $303.19B | $1.40B | 0.46% |
| 2024-09-30 | $293.96B | $1.51B | 0.51% |
| 2024-06-30 | $283.83B | $1.86B | 0.65% |
| 2024-03-31 | $276.54B | $1.85B | 0.67% |
| 2023-12-31 | $271.58B | $1.87B | 0.69% |
| 2023-09-30 | $262.17B | $1.75B | 0.67% |
| 2023-06-30 | $254.43B | $1.69B | 0.66% |
| 2023-03-31 | $247.54B | $1.62B | 0.65% |
| 2022-12-31 | $241.81B | $1.73B | 0.72% |
| 2022-09-30 | $238.59B | $1.70B | 0.71% |
| 2022-06-30 | $236.33B | $1.84B | 0.78% |
| 2022-03-31 | $229.67B | $1.73B | 0.75% |
| 2021-12-31 | $221.10B | $1.61B | 0.73% |
| 2021-09-30 | $213.99B | $1.54B | 0.72% |
| 2021-06-30 | $204.32B | $-3.74B | -1.83% |
| 2021-03-31 | $196.28B | $-3.75B | -1.91% |
| 2020-12-31 | $194.55B | $-3.22B | -1.66% |
| 2020-09-30 | $189.90B | $-3.41B | -1.80% |
| 2020-06-30 | $186.29B | $1.57B | 0.84% |
| 2020-03-31 | $186.16B | $1.58B | 0.85% |
| 2019-12-31 | $182.06B | $0.65B | 0.36% |
| 2019-09-30 | $179.59B | $0.86B | 0.48% |
| 2019-06-30 | $177.25B | $0.96B | 0.54% |
| 2019-03-31 | $175.15B | $0.93B | 0.53% |
| 2018-12-31 | $172.87B | $1.19B | 0.69% |
| 2018-09-30 | $167.94B | $1.66B | 0.99% |
| 2018-06-30 | $163.76B | $1.08B | 0.66% |
| 2018-03-31 | $159.33B | $0.85B | 0.54% |
| 2017-12-31 | $155.44B | $0.98B | 0.63% |
| 2017-09-30 | $153.14B | $0.36B | 0.24% |
| 2017-06-30 | $151.58B | $0.85B | 0.56% |
| 2017-03-31 | $149.76B | $1.15B | 0.77% |
| 2016-12-31 | $148.31B | $1.35B | 0.91% |
| 2016-09-30 | $146.85B | $1.43B | 0.97% |
| 2016-06-30 | $144.76B | $1.64B | 1.13% |
| 2016-03-31 | $142.11B | $1.51B | 1.06% |
| 2015-12-31 | $139.08B | $0.39B | 0.28% |
| 2015-09-30 | $135.96B | $-0.14B | -0.10% |
| 2015-06-30 | $132.08B | $-0.43B | -0.33% |
| 2015-03-31 | $128.20B | $-0.66B | -0.51% |
| 2014-12-31 | $123.98B | $0.03B | 0.03% |
| 2014-09-30 | $119.57B | $0.27B | 0.23% |
| 2014-06-30 | $112.45B | $0.26B | 0.23% |
| 2014-03-31 | $104.01B | $0.44B | 0.42% |
| 2013-12-31 | $96.08B | $0.31B | 0.32% |
| 2013-09-30 | $87.96B | $0.43B | 0.49% |
| 2013-06-30 | $82.23B | $0.55B | 0.66% |
| 2013-03-31 | $79.65B | $0.56B | 0.70% |
| 2012-12-31 | $78.83B | $0.73B | 0.92% |
| 2012-09-30 | $78.08B | $0.72B | 0.92% |
| 2012-06-30 | $78.23B | $0.70B | 0.90% |
| 2012-03-31 | $79.07B | $0.71B | 0.89% |
| 2011-12-31 | $79.12B | $0.71B | 0.89% |
| 2011-09-30 | $78.70B | $0.71B | 0.90% |
| 2011-06-30 | $79.35B | $0.70B | 0.88% |
| 2011-03-31 | $78.79B | $0.68B | 0.86% |
| 2010-12-31 | $78.33B | $0.65B | 0.82% |
| 2010-09-30 | $77.78B | $0.64B | 0.82% |
| 2010-06-30 | $76.96B | $0.63B | 0.81% |
| 2010-03-31 | $75.75B | $0.58B | 0.77% |
| 2009-12-31 | $73.76B | $0.54B | 0.74% |
| 2009-09-30 | $71.76B | $0.50B | 0.70% |
| 2009-06-30 | $70.20B | $0.49B | 0.70% |
| 2009-03-31 | $69.81B | $0.26B | 0.37% |
| 2008-12-31 | $70.25B | $0.25B | 0.36% |
| 2008-09-30 | $70.19B | $0.25B | 0.36% |
| 2008-06-30 | $69.12B | $0.22B | 0.32% |
| 2008-03-31 | $67.47B | $0.46B | 0.68% |
| 2007-12-31 | $66.23B | $0.46B | 0.69% |
| 2007-09-30 | $65.67B | $0.47B | 0.71% |
| 2007-06-30 | $64.83B | $0.50B | 0.78% |
| 2007-03-31 | $64.18B | $0.49B | 0.77% |
| 2006-12-31 | $62.88B | $0.49B | 0.78% |
| 2006-09-30 | $60.81B | $0.47B | 0.77% |
| 2006-06-30 | $59.48B | $0.37B | 0.61% |
| 2006-03-31 | $57.62B | $0.34B | 0.59% |
| 2005-12-31 | $55.59B | $0.31B | 0.56% |
| 2005-09-30 | $54.58B | $0.27B | 0.49% |
| 2005-06-30 | $54.03B | $0.34B | 0.62% |
| 2005-03-31 | $53.25B | $0.37B | 0.69% |
| 2004-12-31 | $53.42B | $0.41B | 0.77% |
| 2004-09-30 | $53.12B | $0.47B | 0.88% |
| 2004-06-30 | $52.32B | $0.50B | 0.95% |
| 2004-03-31 | $51.68B | $0.48B | 0.93% |
| 2003-12-31 | $50.49B | $0.46B | 0.91% |
| 2003-09-30 | $49.59B | $0.44B | 0.89% |
| 2003-06-30 | $48.62B | $0.42B | 0.86% |
| 2003-03-31 | $47.82B | $0.39B | 0.82% |
| 2002-12-31 | $46.60B | $0.37B | 0.79% |
| 2002-09-30 | $45.24B | $0.35B | 0.76% |
| 2002-06-30 | $39.52B | $0.29B | 0.72% |
| 2002-03-31 | $31.42B | $0.23B | 0.73% |
| 2001-12-31 | $23.95B | $0.17B | 0.70% |
| 2001-09-30 | $16.19B | $0.13B | 0.78% |
| 2001-06-30 | $13.34B | $0.12B | 0.88% |
| 2001-03-31 | $12.75B | $0.11B | 0.87% |
| 2000-12-31 | $12.11B | $0.10B | 0.85% |
| 2000-09-30 | $11.65B | $0.10B | 0.85% |
| 2000-06-30 | $11.19B | $0.08B | 0.71% |
| 2000-03-31 | $10.52B | $0.07B | 0.70% |
| 1999-12-31 | $9.86B | $0.07B | 0.71% |
| 1999-09-30 | $9.19B | $0.07B | 0.72% |
| 1999-06-30 | $8.86B | $0.06B | 0.68% |
| 1999-03-31 | $8.69B | $0.06B | 0.64% |
| 1998-12-31 | $8.71B | $0.05B | 0.60% |
| 1998-09-30 | $8.79B | $0.05B | 0.55% |
| 1998-06-30 | $8.76B | $0.06B | 0.71% |
| 1998-03-31 | $8.73B | $0.05B | 0.60% |
| 1997-12-31 | $8.32B | $0.05B | 0.56% |
| 1997-09-30 | $7.82B | $0.05B | 0.58% |
| 1997-06-30 | $7.08B | $0.04B | 0.59% |
| 1997-03-31 | $6.44B | $0.04B | 0.61% |
| 1996-12-31 | $6.02B | $0.04B | 0.63% |
| 1996-09-30 | $5.55B | $0.04B | 0.63% |
| 1996-06-30 | $5.27B | $0.03B | 0.63% |
| 1996-03-31 | $5.04B | $0.03B | 0.68% |
| 1995-12-31 | $3.68B | $0.03B | 0.84% |
| 1995-09-30 | $3.55B | $0.01B | 0.31% |
| 1995-06-30 | $3.43B | $0.00B | 0.03% |
| 1995-03-31 | $3.32B | $-0.18B | -5.51% |
| 1994-12-31 | $4.39B | $-0.19B | -4.24% |
| 1994-09-30 | $4.28B | $-0.21B | -4.87% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |